Skip to main content

Table 4 Comparison of estimates measuring the relation between malaria transmission and mortality from previous studies and current work

From: Modelling the relationship between malaria prevalence as a measure of transmission and mortality across age groups

  Transmission measure Neonates Infants Child Older child Adults Elderly All ages
(All-cause) Log EIRa 3.91 (3.53–4.32) 3.64 (3.40–3.89) 4.29 (3.89–4.73) – – – –
Slide Positivity Rate (Incidence)b 0.89 (0.13–5.70) 3.10 (0.36–13.12) 4.29 (2.78–13.29) 0.48 (0.15–2.05) 0.73 (0.39–1.42) 1.70 (0.79–4.45) 1.55 (1.04–2.80)
Annual parasite prevalencec 1.23 (0.71–2.10) 1.04 (0.75–1.42) 1.11 (0.80–1.52) 1.15 (0.67–1.98) 1.23 (1.01–1.50) 1.04 (0.86–1.28) 1.10 (0.97–1.25)
Annual clinical malaria prevalencec 1.03 (0.44–2.32) 1.22 (0.68–1.84) 1.38 (0.87–2.19) 1.97 (0.88–4.17) 1.16 (0.86–1.58) 0.99 (0.72–1.36) 1.16 (0.97–1.40)
Five-year parasite prevalenced 0.64 (0.29–1.34) 1.32 (0.86–2.04) 1.50 (0.98–2.23) 1.38 (0.69–2.69) 1.23 (0.94–1.57) 1.04 (0.78–1.35) 1.15 (0.96–1.37)
Five-year clinical malaria prevalenced 1.05 (0.30–3.51) 1.65 (0.81–3.26) 1.89 (1.00–3.51) 3.94 (1.34–11.1) 0.99 (0.64–1.54) 1.07 (0.69–1.66) 1.32 (1.01–1.74)
(Malaria-specific) Log EIRa – 4.35 (3.72–4.95) 4.29 (3.61–5.06) – – – –
Slide Positivity Rate (Incidence)b – 1.36 (0.23–9.85) 9.48 (5.11–37.94) 0.02 (0.003–0.33) 0.27 (0.02–3.24) 0.59 (0.01–13.15) 1.37 (0.51–3.73)
Annual parasite prevalencec – 1.31 (0.71–2.37) 1.50 (0.92–2.41) 0.80 (0.32–2.06) 0.78 (0.32–1.80) 3.42 (1.39–8.63) 1.31 (0.95–1.78)
Annual clinical malaria prevalencec – 0.94 (0.34–2.47) 1.58 (0.73–3.23) 3.65 (0.94–12.79) 0.36 (0.08–1.49) 1.67 (0.38–6.52) 1.34 (0.82–2.14)
Five-year parasite prevalenced – 1.73 (0.74–4.21) 2.29 (1.17–4.29) 0.56 (0.14–2.03) 1.55 (0.48–4.86) 2.24 (0.67–7.44) 1.66 (1.07–2.54)
Five-year clinical malaria prevalenced – 2.23 (0.55–8.36) 3.37 (1.23–8.93) 7.56 (1.20–39.5) 0.60 (0.08–3.91) 0.77 (0.09–5.64) 2.50 (1.27–4.81)
  1. Estimates are Bayesian posterior medians and 95% Bayesian Credible Intervals (BCI)
  2. Statistical important effects are indicated in italic
  3. Source: aAmek et al. [34]; bKhagayi et al. [10]
  4. cAnnually aggregated data. Current work
  5. dData aggregated over 4–5 years. Current work
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us